{"title":"医疗保健定价和获取的伦理:一个社会正义问题","authors":"Richard Boudreau","doi":"10.31579/2639-4162/026","DOIUrl":null,"url":null,"abstract":"In most countries in the developed world, healthcare is considered a right, not a privilege. Access to appropriate medical services, including pharmaceuticals, is viewed as a natural part of the commitment of the government to its people. In the United States, though, the focus on pharmaceutical development has led to a kind of “free-for-all” in the industry, where each company strives to produce new products at an alarming rate, with the end goal of profitability and competitive advantage.","PeriodicalId":93288,"journal":{"name":"General medicine and clinical practice","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Ethics of Pricing and Access to Healthcare: A Social Justice Issue\",\"authors\":\"Richard Boudreau\",\"doi\":\"10.31579/2639-4162/026\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In most countries in the developed world, healthcare is considered a right, not a privilege. Access to appropriate medical services, including pharmaceuticals, is viewed as a natural part of the commitment of the government to its people. In the United States, though, the focus on pharmaceutical development has led to a kind of “free-for-all” in the industry, where each company strives to produce new products at an alarming rate, with the end goal of profitability and competitive advantage.\",\"PeriodicalId\":93288,\"journal\":{\"name\":\"General medicine and clinical practice\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-09-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"General medicine and clinical practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31579/2639-4162/026\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"General medicine and clinical practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31579/2639-4162/026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Ethics of Pricing and Access to Healthcare: A Social Justice Issue
In most countries in the developed world, healthcare is considered a right, not a privilege. Access to appropriate medical services, including pharmaceuticals, is viewed as a natural part of the commitment of the government to its people. In the United States, though, the focus on pharmaceutical development has led to a kind of “free-for-all” in the industry, where each company strives to produce new products at an alarming rate, with the end goal of profitability and competitive advantage.